Announced
Completed
ENTASIS THERAPEUTICS LIMITED / TPG BIOTECHNOLOGY PARTNERS V L.P. / SOFINNOVA VENTURE PARTNERS IX LP / PIVOTAL BIOVENTURE PARTNERS LLC / NOVO A/S / FRAZIER LIFE SCIENCES VIII LP / EVENTIDE HEALTHCARE & LIFE SCIENCES FUND / EVENTIDE GILEAD FUND / CLARUS VENTURES LLC / Acquisition / Private / £44m
Synopsis
Equity investment led by Novo Holdings in Entasis Therapeutics, a developer of antibacterials to fight diseases caused by multidrug-resistant bacteria.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
All rights reserved. Copyright © 2025 Datasite